Joshua Boger, Ph.D., founded Vertex in 1989 with $6 million in venture capital and a dream to create a new kind of pharmaceutical company. After more than a decade at Merck, where he was told that most of the medicines he would work on would never make it to a patient, he left and founded Vertex with the idea that no challenge should ever be too great. From the very first day, Vertex has pushed the boundaries of what’s possible in medicine with the simple goal of improving the lives of people with serious diseases.
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies.